Prospective analysis shows distinct oral microbiome patterns in liver transplant patients, indicating potential for early complication risk stratification.
Background and Aims: Oral dysbiosis noted in chronic liver disease (CLD). This may play a role in post-liver transplantation (LT) outcomes. This study aimed to assess the baseline oral microbiome and its association with early complications (EC) within 6 months after liver transplantation (LT). Methods: This prospective longitudinal study included 94 CLD recipients (CR) and their living donors. Patients were managed with a standardized immunosuppressive regimen and monitored for 6 months post-LT EC rejection, infection, biliary complications (BCs), and death. Pre- and post-LT saliva samples were processed for bacterial sequencing, qPCR validation, and cytokine profiling. The association between microbial abundance and EC was assessed. Results : At baseline, CR exhibited a lower Bacteroidota and a higher abundance of Bacillota compared to donors. Streptococcaceae and Veillonellaceae were enriched in CR compared to their respective donors ( p <0.05, each). On follow-up, post-LT early complications were noted in 35/94 patients. Prominent Bacillota, Bacteroidetes, and Actinomycetota were noted at baseline in those who developed rejection, infection, and BC, respectively. Species-level analysis, followed by qPCR validation, revealed complication-specific baseline microbial signatures: E. marmotae (FC 3.9) for rejection, P. salivae (FC 71) for infections, and Rothia (FC 301) and Lactobacillus rhamnosus (FC 51) in BC. The baseline enrichment of Prevotella_7_sp2, Klebsiella pneumoniae, and Staphylococcus was associated with sepsis-related mortality. Recipients with post-LT EC showed pro-inflammatory links ( Prevotella with IL-2, Streptococcus with IL-8). Conclusion : Baseline oral microbiome profiles were differentially abundant among individuals who developed post-LT early complications. Incorporating microbial signatures may enable noninvasive risk stratification after LT.
No takes yet. Share an insight, caveat, or question.
Sureshan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: